Search

In the modern era of medicine, advancements in data science and biomedical technologies have revolutionized our understanding of diseases. Cancer, being a complex disease, has particularly benefited from the wealth of molecular data available, which can now be analyzed using cutting-edge artificial intelligence (AI) and information science methods. In this context, recent studies have increasingly recognized chronic stress as a significant factor in cancer progression. Utilizing computational methods to address this matter has demonstrated encouraging advancements, providing a hopeful outlook in our efforts to combat cancer. This review focuses on recent computational approaches in understanding the molecular links between stress and cancer metastasis. Specifically, we explore the utilization of single-cell data, an innovative technique in DNA sequencing that allows for detailed analysis. Additionally, we explore the application of AI and data mining techniques to these complex and large-scale datasets. Our findings underscore the potential of these computational pipelines to unravel the intricate relationship between stress and cancer metastasis. However, it is important to note that this field is still in its early stages, and we anticipate a proliferation of similar approaches in the near future, further advancing our understanding and treatment of cancer.

The increasing prevalence of metabolic syndrome (MetS), a serious condition associated with elevated risks of cardiovascular diseases, stroke, and type 2 diabetes, underscores the urgent need for effective diagnostic tools. This research carefully examines the effectiveness of 16 diverse machine learning (ML) models in predicting MetS, a multifaceted health condition linked to increased risks of heart disease and other serious health complications. Utilizing a comprehensive, unpublished dataset of imbalanced blood test results, spanning from 2017 to 2022, from the Laboratory Information System of the General Hospital of Amfissa, Greece, our study embarks on a novel approach to enhance MetS diagnosis. By harnessing the power of advanced ML techniques, we aim to predict MetS with greater accuracy using non-invasive blood test data, thereby reducing the reliance on more invasive diagnostic methods. Central to our methodology is the application of the Borda count method, an innovative technique employed to refine the dataset. This process prioritizes the most relevant variables, as determined by the performance of the leading ML models, ensuring a more focused and effective analysis. Our selection of models, encompassing a wide array of ML techniques, allows for a comprehensive comparison of their individual predictive capabilities in identifying MetS. This study not only illuminates the unique strengths of each ML model in predicting MetS but also reveals the expansive potential of these methods in the broader landscape of health diagnostics. The insights gleaned from our analysis are pivotal in shaping more efficient strategies for the management and prevention of metabolic syndrome, thereby addressing a significant concern in public health.

Obsessive-compulsive disorder (OCD) is a chronic psychiatric disease in which patients suffer from obsessions compelling them to engage in specific rituals as a temporary measure to alleviate stress. In this study, deep learning-based methods were used to build three models which predict the likelihood of a molecule interacting with three biological targets relevant to OCD, SERT, D2, and NMDA. Then, an ensemble model based on those models was created which underwent external validation on a large drug database using random sampling. Finally, case studies of molecules exhibiting high scores underwent bibliographic validation showcasing that good performance in the ensemble model can indicate connection with OCD pathophysiology, suggesting that it can be used to screen molecule databases for drug-repurposing purposes.

Background: Glioblastoma multiforme (GBM) is a highly aggressive brain cancer known for its challenging survival rates; it is characterized by distinct subtypes, such as the proneural and mesenchymal states. The development of targeted therapies is critically dependent on a thorough understanding of these subtypes. Advances in single-cell RNA-sequencing (scRNA-seq) have opened new avenues for identifying subtype-specific gene biomarkers, which are essential for innovative treatments. Methods: This study introduces a genetic optimization algorithm designed to select a precise set of genes that clearly differentiate between the proneural and mesenchymal GBM subtypes. By integrating differential gene expression analysis with gene variability assessments, our dual-criterion strategy ensures the selection of genes that are not only differentially expressed between subtypes but also exhibit consistent variability patterns. This approach enhances the biological relevance of identified biomarkers. We applied this algorithm to scRNA-seq data from GBM samples, focusing on the discovery of subtype-specific gene biomarkers. Results: The application of our genetic optimization algorithm to scRNA-seq data successfully identified significant genes that are closely associated with the fundamental characteristics of GBM. These genes show a strong potential to distinguish between the proneural and mesenchymal subtypes, offering insights into the molecular underpinnings of GBM heterogeneity. Conclusions: This study introduces a novel approach for biomarker discovery in GBM that is potentially applicable to other complex diseases. By leveraging scRNA-seq data, our method contributes to the development of targeted therapies, highlighting the importance of precise biomarker identification in personalized medicine.

Lip reading, the art of deciphering spoken words from the visual cues of lip movements, has garnered significant interest for its potential applications in diverse fields, including assistive technologies, human–computer interaction, and security systems. With the rapid advancements in technology and the increasing emphasis on non-verbal communication methods, the significance of lip reading has expanded beyond its traditional boundaries. These technological advancements have led to the generation of large-scale and complex datasets, necessitating the use of cutting-edge deep learning tools that are adept at handling such intricacies. In this study, we propose an innovative approach combining 3D Convolutional Neural Networks (CNNs) and Long Short-Term Memory (LSTM) networks to tackle the challenging task of word recognition from lip movements. Our research leverages a meticulously curated dataset, named MobLip, encompassing various speech patterns, speakers, and environmental conditions. The synergy between the spatial information extracted by 3D CNNs and the temporal dynamics captured by LSTMs yields impressive results, achieving an accuracy rate of up to 87.5%, showcasing robustness to lighting variations and speaker diversity. Comparative experiments demonstrate our model’s superiority over existing lip-reading approaches, underlining its potential for real-world deployment. Furthermore, we discuss ethical considerations and propose avenues for future research, such as multimodal integration with audio data and expanded language support. In conclusion, our 3D CNN-LSTM architecture presents a promising solution to the complex problem of word recognition from lip movements, contributing to the advancement of communication technology and opening doors to innovative applications in an increasingly visual world.

The rapid advancement of high-throughput technologies has led to the generation of vast amounts of omics data, including genomics, epigenomics, and metabolomics. Integrating these diverse datasets has become essential for gaining comprehensive insights into complex biological systems and enhancing personalized healthcare solutions. This critical review examines the current state of multi-omics data integration platforms, highlighting both the strengths and limitations of existing tools. By evaluating the latest digital platforms, such as GraphOmics, OmicsAnalyst, and others, the paper explores how they support seamless integration and analysis of omics data in healthcare applications. Special attention is given to their role in clinical decision-making, disease prediction, and personalized medicine, with a focus on their interoperability, scalability, and usability. The review also discusses the challenges these platforms face, such as data complexity, standardization issues, and the need for improved machine learning and AI-based analytics. Finally, the paper proposes directions for future research and development, emphasizing the importance of more advanced, user-friendly, and secure platforms that can better serve comprehensive healthcare needs.

(1) Background: Parkinson’s disease (PD) is a progressively worsening neurodegenerative disorder affecting movement, mental well-being, sleep, and pain. While no cure exists, treatments like hyperbaric oxygen therapy (HBOT) offer potential relief. However, the molecular biology perspective, especially when intertwined with machine learning dynamics, remains underexplored. (2) Methods: We employed machine learning techniques to analyze single-cell RNA-seq data from human PD cell samples. This approach aimed to identify pivotal genes associated with PD and understand their relationship with HBOT. (3) Results: Our analysis indicated genes such as MAP2, CAP2, and WSB1, among others, as being crucially linked with Parkinson’s disease (PD) and showed their significant correlation with Hyperbaric oxygen therapy (HBOT) indicatively. This suggests that certain genomic factors might influence the efficacy of HBOT in PD treatment. (4) Conclusions: HBOT presents promising therapeutic potential for Parkinson’s disease, with certain genomic factors playing a pivotal role in its efficacy. Our findings emphasize the need for further machine learning-driven research harnessing diverse omics data to better understand and treat PD.

The progressive aging of the global population and the high impact of neurodegenerative diseases, such as Alzheimer’s disease (AD), underscore the urgent need for innovative diagnostic and therapeutic strategies. AD, the most prevalent neurodegenerative disorder among the elderly, is expected to affect 75 million people in developing countries by 2030. Despite extensive research, the precise etiology of AD remains elusive due to its heterogeneity and complexity. The key pathological features of AD, including amyloid-beta plaques and hyperphosphorylated tau protein, are established years before clinical symptoms appear. Recent studies highlight the pivotal role of neuroinflammation in AD pathogenesis, with the chronic activation of the brain’s immune system contributing to the disease’s progression. Pro-inflammatory cytokines, such as TNF-α, IL-1β, and IL-6, are elevated in AD and mild cognitive impairment (MCI) patients, suggesting a strong link between peripheral inflammation and CNS degeneration. There is a pressing need for minimally invasive, cost-effective diagnostic methods. Buccal mucosa cells and saliva, which share an embryological origin with the CNS, show promise for AD diagnosis and prognosis. This study integrates cellular observations with advanced data processing and machine learning to identify significant biomarkers and patterns, aiming to enhance the early diagnosis and prevention strategies for AD.

Real-world problems often exhibit complex relationships and dependencies, which can be effectively captured by graph learning systems. Graph attention networks (GATs) have emerged as a powerful and versatile framework in this direction, inspiring numerous extensions and applications in several areas. In this review, we present a thorough examination of GATs, covering both diverse approaches and a wide range of applications. We examine the principal GAT-based categories, including Global Attention Networks, Multi-Layer Architectures, graph-embedding techniques, Spatial Approaches, and Variational Models. Furthermore, we delve into the diverse applications of GATs in various systems such as recommendation systems, image analysis, medical domain, sentiment analysis, and anomaly detection. This review seeks to act as a navigational reference for researchers and practitioners aiming to emphasize the capabilities and prospects of GATs.

Advancements in molecular biology have revolutionized our understanding of complex diseases, with Alzheimer’s disease being a prime example. Single-cell sequencing, currently the most suitable technology, facilitates profoundly detailed disease analysis at the cellular level. Prior research has established that the pathology of Alzheimer’s disease varies across different brain regions and cell types. In parallel, only machine learning has the capacity to address the myriad challenges presented by such studies, where the integration of large-scale data and numerous experiments is required to extract meaningful knowledge. Our methodology utilizes single-cell RNA sequencing data from healthy and Alzheimer’s disease (AD) samples, focused on the cortex and hippocampus regions in mice. We designed three distinct case studies and implemented an ensemble feature selection approach through machine learning, also performing an analysis of distinct age-related datasets to unravel age-specific effects, showing differential gene expression patterns within each condition. Important evidence was reported, such as enrichment in central nervous system development and regulation of oligodendrocyte differentiation between the hippocampus and cortex of 6-month-old AD mice as well as regulation of epinephrine secretion and dendritic spine morphogenesis in 15-month-old AD mice. Our outcomes from all three of our case studies illustrate the capacity of machine learning strategies when applied to single-cell data, revealing critical insights into Alzheimer’s disease.

Alzheimer’s disease is one of the leading causes of death globally, significantly impacting countless families and communities. In parallel, recent advancements in molecular biology and network approaches, guided by the Network Medicine perspective, offer promising outcomes for Alzheimer’s disease research and treatment. In this study, we aim to discover candidate therapies for AD through drug repurposing. We combined a protein-protein interaction (PPI) network with drug-target interactions. Experimentally validated PPI data were collected from the PICKLE meta-database, while drugs and their protein targets were sourced from the DrugBank database. Then, based on RNA-Seq data, we first assigned weights to edges to indicate co-expression, and secondly, estimated differential gene expression to select a subset of genes potentially related to the disease. Finally, small subgraphs (modules) were extracted from the graph, centered on the genes of interest. The analysis revealed that even if there is no drug targeting several genes of interest directly, an existing drug might target a neighboring node, thus indirectly affecting the aforementioned genes. Our approach offers a promising method for treating various diseases by repurposing existing drugs, thereby reducing the cost and time of experimental procedures and paving the way for more precise Network Medicine strategies.